Analytical Data
-
基因名
BENE
- Application
-
别名
MALL; BENE; MAL-like Protein; Protein BENE
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q13021
-
表达区间
1-153aa
-
氨基酸序列
MASPDPPATSYAPSDVPSGVALFLTIPFAFFLPELIFGFLVWTMVAATHIVYPLLQGWVMYVSLTSFLISLMFLLSYLFGFYKRFESWRVLDSLYHGTTGILYMSAAVLQVHATIVSEKLLDPRIYYINSAASFFAFIATLLYILHAFSIYYH
-
分子量
42.57 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BENE is a recombinant protein that has garnered significant interest in the field of biotechnology and pharmaceuticals. The research into BENE stems from the need to understand its structure and function, as well as its potential applications in therapeutic development. The protein is derived from a specific biological source, which gives it unique properties that may be beneficial in treating various diseases. Scientists are particularly focused on elucidating the mechanisms by which BENE interacts with cellular pathways, as this knowledge could lead to innovative treatments for conditions such as cancer and autoimmune disorders. Additionally, BENE's ability to stimulate immune responses makes it a candidate for vaccine development. As the demand for effective and targeted therapies continues to rise, BENE represents a promising avenue for research aimed at enhancing the efficacy of existing treatments and paving the way for new therapeutic strategies. Collaborative efforts across multiple disciplines, including molecular biology, biochemistry, and pharmacology, are crucial to advancing our understanding of BENE and unlocking its full potential in medical applications.
